Task: Answer the multiple choice question.
Question: Which drug exhibits a 17.264\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) COc1ccccc1NC(=S)NCc1ccc(F)cc1
b) Cc1nn(Cc2ccccc2Cl)c(C)c1NC(=O)c1nc2ncccn2n1
Answer: b. Cc1nn(Cc2ccccc2Cl)c(C)c1NC(=O)c1nc2ncccn2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nn(Cc2ccccc2Cl)c(C)c1NC(=O)c1nc2ncccn2n1
Cc1nn(Cc2ccccc2Cl)c(C)c1NC(=O)c1nc2ncccn2n1
N-[2-[(2-chlorophenyl)methyl]-3,5-dimethylpyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide